Device Trial Radar · NCT03131544
MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH)
Last checked: Nov 19, 2026Latest source record: Apr 25, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Apr 17, 2017
Primary completion
Oct 15, 2018
Study completion May 15, 2020
Sponsor
- Lead sponsor
- Prostate Laser Center, PLLCNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Medtronic
- First posted
- Apr 27, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Over 100,000 BPH procedures are performed annually in the US. The purpose of this study is to evaluate the effectiveness of performing MRI guided transrectal laser ablation using a 980 nm laser (VisualaseTM by Medtronic, Inc., a Minnesota, U.S.A. company) to treat benign prostatic hypertrophy (BPH). The laser system will be used to necrotize urological soft tissue within the prostate under MRI guidance. This will be a single center, single arm prospective trial with an anticipated enrollment of 10 men. Patients who elect this treatment option and choose to be part of the study will be enrolled consecutively.
Conditions
- BPH
- Prostate Hyperplasia
- Urinary Frequency/Urgency
Interventions
MRI Guided Transrectal Periuretheral Transitional Zone AblationDevice
Patients will undergo an MRI guided transrectal ablation of tissue within the periuretheral transitional zone.
Primary outcomes
What the sponsor says the trial is designed to measure.
- International Prostate Symptom Score (IPSS) ChangeTime frame: From baseline to 2 months
- International Prostate Symptom Score (IPSS) Quality of Life (QoL) Question ChangeTime frame: From baseline to 2 months
- BPH Impact Index ChangeTime frame: From baseline to 2 months
14 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Prostate Laser Center, PLLC
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.